Phase 1 Parkinson's Disease (PD) Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease
Healthy Volunteers (HV)Parkinson's Disease (PD)
Vertero Therapeutics84 enrolled1 locationNCT07310264
Recruiting
Phase 1
A Phase Ib Trial of Combined Febuxostat and Inosine Therapy in Patients With Parkinson's Disease
Parkinson's Disease (PD)
Fujita Health University24 enrolled1 locationNCT07170475
Completed
Phase 1
A study to evaluate safety, tolerability and pharmacokinetics of ELVN-001 in Normal Healthy Participants- Part B
Parkinson's Disease (PD)Chronic Myeloid Leukaemia (CML)
Enliven Therapeutics, Inc.15 enrolled1 locationACTRN12624000116527
Completed
Phase 1
A study to evaluate safety, tolerability and pharmacokinetics of ELVN-001 in Normal Healthy Participants- Part A
Parkinson's Disease (PD)Chronic Myeloid Leukaemia (CML)
Enliven Therapeutics, Inc.15 enrolled1 locationACTRN12624000115538